Dbv Technologies SA
DBVT10.300USD
-0.190-1.81%
收盤 07/02, 16:00（美東）報價延遲15分鐘
1.06B總市值
虧損本益比TTM
關於 Dbv Technologies SA 公司
DBV Technologies SA 是一家總部位於法國的臨牀階段生物製藥公司，致力於通過開發名爲 Vaskin 的技術平臺改變免疫療法領域。該公司的治療方法基於表皮免疫療法 (EPIT)，這是其專有方法，使用 Viaskin 通過完整的皮膚將生物活性化合物輸送到免疫系統。該公司致力於將其技術用於治療患有嚴重食物過敏的患者（包括嬰兒和兒童），對他們來說，安全至關重要，因爲有害過敏原進入他們的血液會引起嚴重或危及生命的過敏反應，例如過敏性休克。該公司的過敏治療產品組合包括 Viaskin Peanut、Viaskin Milk 和 Viaskin Egg。該公司在美國經營一家子公司 DBV Technologies Inc.。
公司簡介
公司代碼DBVT
公司名稱Dbv Technologies SA
上市日期Mar 29, 2012
成立日期2002
CEOMr. Daniel Tasse
員工數量108
證券類型Depository Receipt
年結日Mar 29
公司地址Batiment IRO
城市CHATILLON
上市交易所NASDAQ Capital Market Consolidated
國家France
郵編92320
電話33155427878
網址https://www.dbv-technologies.com/
公司代碼DBVT
上市日期Mar 29, 2012
成立日期2002
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel B. (Dan) Soland
Mr. Daniel B. (Dan) Soland
Non-Executive Independent Director
Non-Executive Independent Director
2.00K
--
Ms. Mailys Ferrere
Ms. Mailys Ferrere
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Michael J. Goller
Mr. Michael J. Goller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Ravi M. Rao, Ph.D.
Dr. Ravi M. Rao, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pharis Mohideen, M.D.
Dr. Pharis Mohideen, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Virginie Boucinha
Ms. Virginie Boucinha
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel Tasse
Mr. Daniel Tasse
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Daniele Guyot-Caparros
Ms. Daniele Guyot-Caparros
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Julie O'Neill
Ms. Julie O'Neill
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Katie Matthews
Ms. Katie Matthews
Investor Relations
Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel B. (Dan) Soland
Mr. Daniel B. (Dan) Soland
Non-Executive Independent Director
Non-Executive Independent Director
2.00K
--
Ms. Mailys Ferrere
Ms. Mailys Ferrere
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Michael J. Goller
Mr. Michael J. Goller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Ravi M. Rao, Ph.D.
Dr. Ravi M. Rao, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pharis Mohideen, M.D.
Dr. Pharis Mohideen, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Virginie Boucinha
Ms. Virginie Boucinha
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 6月2日 週一
更新時間: 6月2日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Baker Bros. Advisors LP
1.07%
Yiheng Capital Management, L.P.
0.48%
UBS Financial Services, Inc.
0.12%
Cantor Fitzgerald, L.P
0.07%
Morgan Stanley & Co. International Plc
0.03%
Other
98.24%
持股股東
持股股東
佔比
Baker Bros. Advisors LP
1.07%
Yiheng Capital Management, L.P.
0.48%
UBS Financial Services, Inc.
0.12%
Cantor Fitzgerald, L.P
0.07%
Morgan Stanley & Co. International Plc
0.03%
Other
98.24%
股東類型
持股股東
佔比
Hedge Fund
1.07%
Investment Advisor
0.68%
Research Firm
0.03%
Venture Capital
0.03%
Other
98.20%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
65
2.48M
1.81%
-1.70M
2025Q1
68
2.48M
1.81%
-1.72M
2024Q4
69
2.75M
14.25%
-1.75M
2024Q3
71
3.24M
16.85%
-1.47M
2024Q2
79
3.44M
17.88%
-1.57M
2024Q1
79
3.80M
19.76%
-1.19M
2023Q4
86
3.80M
19.69%
-1.09M
2023Q3
94
4.46M
23.21%
-1.44M
2023Q2
90
4.62M
24.57%
-904.51K
2023Q1
88
4.26M
22.75%
-1.22M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Baker Bros. Advisors LP
1.46M
1.07%
--
--
Mar 31, 2025
Yiheng Capital Management, L.P.
656.31K
0.48%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
163.49K
0.12%
+1.11K
+0.68%
Mar 31, 2025
Cantor Fitzgerald, L.P
95.46K
0.07%
+95.46K
--
Mar 31, 2025
Morgan Stanley & Co. International Plc
37.22K
0.03%
-5.35K
-12.57%
Mar 31, 2025
Nan Fung Life Sciences
37.09K
0.03%
--
--
Mar 31, 2025
AllianceBernstein L.P.
11.38K
0.01%
+6.37K
+127.13%
Jun 30, 2024
Optiver Holding B.V.
8.35K
0.01%
+8.31K
+23.09K%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
3.89K
0%
+991.00
+34.18%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
3.05K
0%
-100.00
-3.17%
Mar 31, 2025
查看更多
持股ETF
更新時間: 22 小時前
更新時間: 22 小時前
機構名稱
佔比
iShares Biotechnology ETF
0%
ActivePassive International Equity ETF
0%
iShares Biotechnology ETF
佔比0%
ActivePassive International Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Nov 13, 2024
Merger
5<1
Nov 13, 2024
Merger
5<1
Nov 13, 2024
Merger
5<1
Nov 13, 2024
Merger
5<1
May 17, 2024
Merger
2<1
May 17, 2024
Merger
2<1
公告日期
類型
比率
Nov 13, 2024
Merger
5<1
Nov 13, 2024
Merger
5<1
Nov 13, 2024
Merger
5<1
Nov 13, 2024
Merger
5<1
May 17, 2024
Merger
2<1
May 17, 2024
Merger
2<1
May 17, 2024
Merger
2<1
May 17, 2024
Merger
2<1
